Elder pharma eyes buyouts in Africa, Asia

The Rs 600-crore Elder Pharmaceuticals, having emerged as one of the fastest growing pharma companies in India, has outlined growth plans for international markets.

The Rs 600-crore Elder Pharmaceuticals, having emerged as one of the fastest growing pharma companies in India, has outlined growth plans for international markets.

HT Image

“We would soon enjoy a pan-European presence, covering all the key markets of Europe which would enable us to spread our footprints across the world — both in regulated and unregulated markets,” said Alok Saxena, director, Elder Pharmacauticas. “Internationally we are looking at inorganic growth and are planning at strategic acquisitions of brands or companies in Africa and Asia.”

However, he did not quantify the amount earmarked for overseas acquisitions or the specific time frame.